Huntington’s disease symptoms reduced by new peptide-polymer therapy
Scientists at Northwestern and Case Western Reserve universities have developed the first polymer-based therapeutic for Huntington's disease, an incurable, debilitating illness that causes nerve cells to break down in the brain.
4 Nov 04:17 · News-Medical